Overcoming Barriers to Use of SGLT2 Inhibitor Therapy: The Battle Against Clinical Inertia.
Publication
, Journal Article
Greene, SJ; Pierce, JB
Published in: JACC Heart Fail
August 2023
Duke Scholars
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
August 2023
Volume
11
Issue
8 Pt 1
Start / End Page
943 / 945
Location
United States
Related Subject Headings
- Sodium-Glucose Transporter 2 Inhibitors
- Hypoglycemic Agents
- Humans
- Heart Failure
- Diabetes Mellitus, Type 2
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Greene, S. J., & Pierce, J. B. (2023). Overcoming Barriers to Use of SGLT2 Inhibitor Therapy: The Battle Against Clinical Inertia. JACC Heart Fail, 11(8 Pt 1), 943–945. https://doi.org/10.1016/j.jchf.2023.05.006
Greene, Stephen J., and Jacob B. Pierce. “Overcoming Barriers to Use of SGLT2 Inhibitor Therapy: The Battle Against Clinical Inertia.” JACC Heart Fail 11, no. 8 Pt 1 (August 2023): 943–45. https://doi.org/10.1016/j.jchf.2023.05.006.
Greene SJ, Pierce JB. Overcoming Barriers to Use of SGLT2 Inhibitor Therapy: The Battle Against Clinical Inertia. JACC Heart Fail. 2023 Aug;11(8 Pt 1):943–5.
Greene, Stephen J., and Jacob B. Pierce. “Overcoming Barriers to Use of SGLT2 Inhibitor Therapy: The Battle Against Clinical Inertia.” JACC Heart Fail, vol. 11, no. 8 Pt 1, Aug. 2023, pp. 943–45. Pubmed, doi:10.1016/j.jchf.2023.05.006.
Greene SJ, Pierce JB. Overcoming Barriers to Use of SGLT2 Inhibitor Therapy: The Battle Against Clinical Inertia. JACC Heart Fail. 2023 Aug;11(8 Pt 1):943–945.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
August 2023
Volume
11
Issue
8 Pt 1
Start / End Page
943 / 945
Location
United States
Related Subject Headings
- Sodium-Glucose Transporter 2 Inhibitors
- Hypoglycemic Agents
- Humans
- Heart Failure
- Diabetes Mellitus, Type 2
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology